PRME Competitors & Alternatives
Compare Prime Medicine, Inc. Common Stock with similar stocks in the same industry
Biotechnology
PRME
Main Stock$3.48
Tradestie Score
58
Market Cap
$996.55M
Revenue Growth
-0.4%
Analyst Upside
+104.8%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TBPH
Theravance Biopharma, Inc.
|
$16.98
|
$726.21M | 7.6 | 52 | Compare |
|
NRIX
Nurix Therapeutics, Inc. Common stock
|
$23.09
|
$718.62M | - | 61 | Compare |
|
TYRA
Tyra Biosciences, Inc. Common Stock
|
$32.57
|
$715.25M | - | 61 | Compare |
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
|
$704.73M | - | 59 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$146.13
|
$699.30M | - | 61 | Compare |
|
GYRE
Gyre Therapeutics, Inc. Common Stock
|
$6.38
|
$688.47M | - | 56 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 57 | Compare |
|
ARVN
Arvinas, Inc
|
$8.05
|
$670.30M | - | 48 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$12.40
|
$665.30M | - | 59 | Compare |
|
ANL
ANL
|
$9.28
|
$635.61M | - | 49 | Compare |
More PRME Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry